Northbrook, Illinois-based IDEX Corporation (IEX) is an applied solutions company specializing in a range of applications such as fluid and metering technologies, health and science technologies, and fire, safety, and other products. With a market cap of $13.8 billion, IDEX operations span the Americas, Europe, and the Indo-Pacific.

The industrial major is expected to release its Q2 results after the market closes on Wednesday, Jul. 30. Ahead of the event, analysts expect IEX to deliver a profit of $1.99 per share, down 3.4% from $2.06 per share reported in the year-ago quarter. On a positive note, the company has surpassed the Street’s bottom-line estimates in each of the past four quarters.

For the full fiscal 2025, analysts expect IEX to report an EPS of $8.21, up 4.1% from $7.89 reported in the previous year. While in fiscal 2026, its earnings are expected to grow 8.3% year-over-year to $8.89 per share.

IEX stock has dropped 5.6% over the past 52 weeks, notably underperforming the Industrial Select Sector SPDR Fund’s (XLI) 24.1% surge and the S&P 500 Index’s ($SPX) 12.3% returns during the same time frame.

IDEX’s stock prices rose 3.5% in the trading session after the release of its Q1 results on May 1. While the company’s organic sales took a slight hit during the quarter, its overall topline inched up 1.7% year-over-year to $814.3 million, surpassing the Street’s expectations. Although its adjusted EPS for the quarter dropped 6.9% year-over-year to $1.75, it was 6.7% ahead of the consensus estimates. Moreover, the company’s orders touched a record $872 million, boosting investor confidence.

The stock holds a consensus “Moderate Buy” rating overall. Of the 11 analysts covering the stock, opinions include six “Strong Buys,” one “Moderate Buy,” and four “Holds.” Its mean price target of $208.10 indicates a 12.9% upside potential from current price levels.